Font Size: a A A
Keyword [Prostate-Specific Antigen(PSA)]
Result: 21 - 37 | Page: 2 of 2
21. Value Of Combined Use Of MRS, FPSA/tPSA And PSAD In Diagnosing Prostate Cancers At PSA Gray Zone
22. Research On Relationship Between ABO Blood Groups And Prostate Specific Antigen(psa) Level In The Male Benign Prostatic Hyperplasia(BPH)
23. To Study The Relationship Of Scores Of Gleason, PSA And AGE In Prostate Cancer Metastases
24. The Differential Diagnosis Value Of Prostate Specific Antigen (PSA) And Free PSA Ratio On Prostate Cancer And Benign Prostate Hyperplasia
25. Clinical Significances Of Zinc, PSA And Routine Inspection Index Of Expressed Prostatic Secretion In Diagnosis And Treatment Of Chronic Nonbacterial Prostatitis
26. To Comepare The Concordance Rate In Gleason Score Between Needle Biopsy And Prostatectomy Specimens In Prostate Cancer And An Analysis Of Correlative Influence Factors
27. The Application Of Neurotensin In Neuroendocrine Differentiation Of Castration Resistant Prostate Cancer
28. Application Of Electrochemical Biosensor Based On Porous Metal And Covalent Organic Material In The Detection Of Disease Markers
29. The Diagnostic Value Of Prostate Specific Antigen,MRI+MRS,Combined With Transrectal Ultrasound Prostate Biopsy On Prostate Cancer
30. Clinical Evaluation Of Serum IL-6 With Prostate Cancer And A Preliminary Study Of The Function
31. The Preliminary Applicability Evaluation Of PI-RADS V2 Diagnostic Score In 3.0T Mp-MRI Combined With PSAD For Prostate Cancer
32. Risk Factors Analysis For Progression To Castration-resistant Prostate Cancer After Prostate Cancer Treated With Endocrine Therapy Within 1 Year
33. Diagnostic Prediction Model And Follow-up Mechanism Of PSA “grey Area” Prostate Cancer In Han Chinese Men In Southern China
34. Analysis Of The Correlation Between Female Bladder Neck Tissue And Male Prostate Tissue
35. Analysis Of The Efficacy Of Endocrine Combined With Palliative Prostatectomy In Patients With Advanced Prostate Cancer With Bladder Outlet Obstruction
36. Research On The Correlation Between EGF, EGFR, PSA And Prostate Hyperplasia And Prostate Cancer
37. The Diagnostic Value Of PSAD Combined With MRS For PSA<10ng/ml Prostate Carcinoma
  <<First  <Prev  Next>  Last>>  Jump to